Clinical Trials Browser

Terminated × Prostatic Neoplasms × Immune Checkpoint Inhibitors × Clear all

NCT03792841 2025-10-16

Safety, Tolerability, Pharmacokinetics, and Efficacy of Acapatamab in Subjects With mCRPC

Phase 1 Terminated

Bites and Stings, Prostatic Neoplasms